Arbutus Biopharma Corp (ABUS)
3.21
0.00 (0.00%)
USD |
NASDAQ |
Dec 20, 16:00
3.22
+0.01
(+0.31%)
After-Hours: 20:00
Arbutus Biopharma Shareholders Equity (Quarterly): 106.89M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 5.413B |
| Amicus Therapeutics Inc | 178.82M |
| Ionis Pharmaceuticals Inc | 662.47M |
| GlycoMimetics Inc | 11.38M |
| FibroGen Inc | -243.67M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 140.44M |
| Total Liabilities (Quarterly) | 33.55M |
| Current Ratio | 7.017 |